MDT moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on MDT as a result. In 47 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for MDT just turned positive on October 12, 2026. Looking at past instances where MDT's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.
The 50-day moving average for MDT moved above the 200-day moving average on September 17, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDT advanced for three days, in 170 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for MDT crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
MDT broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MDT entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.279) is normal, around the industry mean (10.930). P/E Ratio (22.044) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (11.052). MDT's Dividend Yield (0.032) is considerably higher than the industry average of (0.002). P/S Ratio (3.176) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. MDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
SIBN broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 34 of the 42 cases the stock fell afterwards. This puts the odds of success at 81%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for SIBN entered a downward trend on September 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on SIBN as a result. In 61 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on October 05, 2026. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in 32 of 50 cases over the following month. The odds of a continued upward trend are 64%.
SIBN moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SIBN crossed bullishly above the 50-day moving average on October 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +6.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in 211 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.610) is normal, around the industry mean (10.930). P/E Ratio (0.000) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.801) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
MDT | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 36 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 68 | 93 | |
PRICE GROWTH RATING 1..100 | 30 | 39 | |
P/E GROWTH RATING 1..100 | 57 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (4) in the Medical Specialties industry is in the same range as SIBN (34). This means that MDT’s stock grew similarly to SIBN’s over the last 12 months.
MDT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SIBN (100). This means that MDT’s stock grew similarly to SIBN’s over the last 12 months.
MDT's SMR Rating (68) in the Medical Specialties industry is in the same range as SIBN (93). This means that MDT’s stock grew similarly to SIBN’s over the last 12 months.
MDT's Price Growth Rating (30) in the Medical Specialties industry is in the same range as SIBN (39). This means that MDT’s stock grew similarly to SIBN’s over the last 12 months.
MDT's P/E Growth Rating (57) in the Medical Specialties industry is somewhat better than the same rating for SIBN (100). This means that MDT’s stock grew somewhat faster than SIBN’s over the last 12 months.
| MDT | SIBN | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 42% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 55% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 55% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 55% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 50% | 1 day ago 79% |
| Advances ODDS (%) | 1 day ago 54% | 3 days ago 76% |
| Declines ODDS (%) | 8 days ago 55% | 1 day ago 77% |
| BollingerBands ODDS (%) | 1 day ago 42% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 45% | 1 day ago 80% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MDT’s FA Score shows that 2 FA rating(s) are green while SIBN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MDT’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 5 bullish TA indicator(s).
MDT (@Medical/Nursing Services) experienced а +10.20% price change this week, while SIBN (@Medical/Nursing Services) price change was +1.94% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.79%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -14.87%.
MDT is expected to report earnings on Nov 24, 2026.
SIBN is expected to report earnings on Nov 09, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To SIBN | 1D Price Change % | ||
|---|---|---|---|---|
| SIBN | 100% | -1.07% | ||
| ATEC - SIBN | 54% Loosely correlated | -3.51% | ||
| MDT - SIBN | 45% Loosely correlated | +1.31% | ||
| OFIX - SIBN | 45% Loosely correlated | -0.11% | ||
| STE - SIBN | 42% Loosely correlated | -0.23% | ||
| ENOV - SIBN | 41% Loosely correlated | -2.21% | ||
More | ||||